Redox-regulating role of insulin: The essence of insulin effect

Molecular and Cellular Endocrinology

Volumn 349, Issue 2, 2012, Pages 111-127

  Wang, Xin ^a   Tao, Ling ^b   Hai, Chun X ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant; Insulin; Nrf2; Oxidative stress; Redox

Indexed keywords

CATALASE; GLUCOSE; GLUTATHIONE; HEME OXYGENASE 1; INSULIN; NITRIC OXIDE SYNTHASE; POTASSIUM; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOREDOXIN; ANTIOXIDANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFE2L2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR NRF2;

ACUTE CORONARY SYNDROME; ANTIOXIDANT ACTIVITY; BIOLOGICAL ACTIVITY; CELL METABOLISM; CELL PROTECTION; DIABETES MELLITUS; DNA DAMAGE; DRUG EFFICACY; ENZYME REGULATION; GENE ACTIVATION; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HEART INFARCTION; HORMONAL REGULATION; HUMAN; INSULIN TREATMENT; LIPID PEROXIDATION; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; GLYCOSYLATION; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS; DNA DAMAGE; GLUCOSE; GLYCOSYLATION; HUMANS; INSULIN; LIPID PEROXIDATION; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84859248913     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.08.019     Document Type: Review

References (222)

1. Abramovitz M., Ishigaki S., Listowsky I. Differential regulation of glutathione S-transferases in cultured hepatocytes. Hepatology 1989, 9:235-239.
2. Aikawa R., Nawano M., Gu Y., Katagiri H., Asano T., Zhu W., Nagai R., Komuro I. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 2000, 102:2873-2879.
3. Alam J., Stewart D., Touchard C., Boinapally S., Choi A.M., Cook J.L. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 1999, 274:26071-26078.
4. Aleksunes L.M., Reisman S.A., Yeager R.L., Goedken M.J., Klaassen C.D. Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice. J. Pharmacol. Exp. Ther. 2010, 333:140-151.
5. Aljada A., Ghanim H., Saadeh R., Dandona P. Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells. J. Clin. Endocrinol. Metab. 2001, 86:450-453.
6. Arcaro G., Cretti A., Balzano S., Lechi A., Muggeo M., Bonora E., Bonadonna R.C. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002, 105:576-582.
7. Avila-Gomez I.C., Velez-Pardo C., Jimenez-Del-Rio M. Effects of insulin-like growth factor-1 on rotenone-induced apoptosis in human lymphocyte cells. Basic Clin. Pharmacol. Toxicol. 2010, 106:53-61.
8. Avogaro A., de Kreutzenberg S.V., Fadini G.P. Oxidative stress and vascular disease in diabetes: is the dichotomization of insulin signaling still valid?. Free Radic. Biol. Med. 2008, 44:1209-1215.
9. Baker K., Marcus C.B., Huffman K., Kruk H., Malfroy B., Doctrow S.R. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. J. Pharmacol. Exp. Ther. 1998, 284:215-221.
10. Bedetti G., Pizzi C., Gabrieli L., Varga A., Pasanisi E., Bugiardini R., Picano E. The beneficial effect of insulin, glucose, and dipyridamole on regional left ventricular function early after acute myocardial infarction. Int. J. Cardiol. 2005, 102:255-258.
11. Benz C.C., Yau C. Ageing, oxidative stress and cancer: paradigms in parallax. Nat. Rev. Cancer 2008, 8:875-879.
12. Bertrand F., Desbois-Mouthon C., Cadoret A., Prunier C., Robin H., Capeau J., Atfi A., Cherqui G. Insulin antiapoptotic signaling involves insulin activation of the nuclear factor kappaB-dependent survival genes encoding tumor necrosis factor receptor-associated factor 2 and manganese-superoxide dismutase. J. Biol. Chem. 1999, 274:30596-30602.
13. Bertuglia S., Giusti A., Fedele S., Picano E. Glucose-insulin-potassium treatment in combination with dipyridamole inhibits ischaemia-reperfusion-induced damage. Diabetologia 2001, 44:2165-2170.
14. Beyer T.A., Werner S. The cytoprotective Nrf2 transcription factor controls insulin receptor signaling in the regenerating liver. Cell Cycle 2008, 7:874-878.
15. Beyer T.A., Xu W., Teupser D., Keller U.A.D., Bugnon P., Hildt E., Thiery J., Kan Y.W., Werner S. Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance. EMBO J. 2008, 27:212.
16. Biasi F., Bosco M., Chiappino I., Lanfranco G., Ottobrelli A., Massano G., Donadio P.P., Vaj M., Adoreno E. Oxidative damage in human liver transplantation. Free Radic. Biol. Med. 1995, 19:311-317.
17. Bloom D.A., Jaiswal A.K. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H: quinone oxidoreductase-1 gene expression. J. Biol. Chem. 2003, 278:44675-44682.
18. Bravi M.C., Armiento A., Laurenti O., Cassone-Faldetta M., De Luca O., Moretti A., De Mattia G. Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus. Metabolism 2006, 55:691-695.
19. Cai J., Sun W.M., Lu S.C. Hormonal and cell density regulation of hepatic gamma-glutamylcysteine synthetase gene expression. Mol. Pharmacol. 1995, 48:212-218.
20. Carrillo M.C., Monti J.A., Favre C., Carnovale C.E. Acute regulation of hepatic glutathione S-transferase by insulin and glucagon. Toxicol. Lett. 1995, 76:105-111.
21. Castilla-Cortazar I., Garcia M., Muguerza B., Quiroga J., Perez R., Santidrian S., Prieto J. Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology 1997, 113:1682-1691.
22. Ceda G.P., Dall'Aglio E., Maggio M., Lauretani F., Bandinelli S., Falzoi C., Grimaldi W., Ceresini G., Corradi F., Ferrucci L., Valenti G., Hoffman A.R. Clinical implications of the reduced activity of the GH-IGF-I axis in older men. J. Endocrinol. Invest. 2005, 28:96-100.
23. Ceolotto G., Papparella I., Lenzini L., Sartori M., Mazzoni M., Iori E., Franco L., Gallo A., de Kreutzenberg S.V., Tiengo A., Pessina A.C., Avogaro A., Semplicini A. Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin. Free Radic. Biol. Med. 2006, 41:473-483.
24. Chang C.L., Au L.C., Huang S.W., Fai K.C., Ho L.T., Juan C.C. Insulin up-regulates heme oxygenase-1 expression in 3T3-L1 adipocytes via PI3-kinase- and PKC-dependent pathways and heme oxygenase-1-associated microRNA downregulation. Endocrinology 2011, 152:384-393.
25. Cheng J.C., Chou C.H., Kuo M.L., Hsieh C. Radiation enhanced MMP-9 dependent migration/invasion in hepatocellular carcinoma cell through PI3K/Akt/NF-kB or MAPK/ERK/NF-kB pathways. Proc. Am. Assoc. Cancer Res. 2005, 46:5690.
26. Cho H.Y., Jedlicka A.E., Reddy S.P., Kensler T.W., Yamamoto M., Zhang L.Y., Kleeberger S.R. Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 2002, 26:175-182.
27. Cioffi W.G., Gore D.C., Rue L.W.R., Carrougher G., Guler H.P., McManus W.F., Pruitt B.A. Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury. Ann. Surg. 1994, 220:310-316.
28. Cohen G. Oxy-radical toxicity in catecholamine neurons. Neurotoxicology 1984, 5:77-82.
29. Diabetes Control and Complications Trial Research Group, 1994. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: diabetes Control and Complications Trial. J. Pediatr 125, 177-188.
30. Dan H.C., Cooper M.J., Cogswell P.C., Duncan J.A., Ting J.P., Baldwin A.S. Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Dev. 2008, 22:1490-1500.
31. Dandona P., Mohanty P., Ghanim H., Aljada A., Browne R., Hamouda W., Prabhala A., Afzal A., Garg R. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J. Clin. Endocrinol. Metab. 2001, 86:355-362.
32. Dandona P., Aljada A., Mohanty P., Ghanim H., Hamouda W., Assian E., Ahmad S. Insulin inhibits intranuclear nuclear factor kB and stimulates IkB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. J. Clin. Endocrinol. Metab. 2001, 86:3257-3265.
33. Dandona P., Aljada A., Dhindsa S., Garg R. Insulin as an anti-inflammatory and antiatherosclerotic hormone. Clin. Cornerstone Suppl. 2003, 4:13-20.
34. Dandona P., Aljada A., O'donnell A., Dhindsa S., Garg R. Insulin is an anti-inflammatory and anti-atherosclerotic hormone. Metab. Syndr. Relat. Disord 2004, 2:137-142.
35. Dandona P., Chaudhuri A., Mohanty P., Ghanim H. Anti-inflammatory effects of insulin. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10:511-517.
36. Dandona P., Chaudhuri A., Ghanim H., Mohanty P. Insulin as an anti-inflammatory and antiatherogenic modulator. J. Am. Coll. Cardiol. 2009, 53:14-20.
37. Dandona P., Ghanim H., Bandyopadhyay A., Korzeniewski K., Ling S.C., Dhindsa S., Chaudhuri A. Insulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humans. Diabetes Care 2010, 33:2416-2423.
38. de Souza F.S., Wainstein M.V., Polanczyk C.A., Ledur P., Lazzari C.M., Klein C., Hackenhaar F.S., Benfato M.S., Schaan B.D. Inflammatory and oxidative stress markers after intravenous insulin in percutaneous coronary intervention with stent in type 2 diabetes mellitus: a randomized controlled trial. J. Clin. Endocrinol. Metab. 2011, 96:478-485.
39. Demircan S., Yazici M., Diraman E., Demircan G., Kilicaslan F., Durna K., Acar Z., Eren Z. The effect of glucose-insulin-potassium treatment on myocardial oxidative stress in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Coron. Artery Dis. 2008, 19:99-104.
40. Demple B., Amabile-Cuevas C.F. Redox redux: the control of oxidative stress responses. Cell 1991, 67:837-839.
41. Dickinson D.A., Forman H.J. Glutathione in defense and signaling. Lessons from a small thiol. Ann. NY Acad. Sci. 2002, 973:488-504.
42. Diraman E., Demircan G., Demircan S., Yazici M., Durna K., Ural F., Eren Z. Effect of glucose-insulin-potassium infusion on oxidative stress in patients with dilated cardiomyopathy. Exp. Clin. Cardiol. 2008, 13:79-84.
43. Dong J., Sulik K.K., Chen S.Y. Nrf2-mediated transcriptional induction of antioxidant response in mouse embryos exposed to ethanol in vivo: implications for the prevention of fetal alcohol spectrum disorders. Antioxid. Redox Signal. 2008, 10:2023-2033.
44. Draznin B., Miles P., Kruszynska Y., Olefsky J., Friedman J., Golovchenko I., Stjernholm R., Wall K., Reitman M., Accili D., Cooksey R., McClain D., Goalstone M. Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia. Endocrinology 2000, 141:1310-1316.
45. Dreger H., Westphal K., Weller A., Baumann G., Stangl V., Meiners S., Stangl K. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovasc. Res. 2009, 83:354-361.
46. Droge W., Kinscherf R. Aberrant insulin receptor signaling and amino acid homeostasis as a major cause of oxidative stress in aging. Antioxid. Redox Signal. 2008, 10:661-678.
47. Duarte A.I., Santos M.S., Oliveira C.R., Rego A.C. Insulin neuroprotection against oxidative stress in cortical neurons-involvement of uric acid and glutathione antioxidant defenses. Free Radic. Biol. Med. 2005, 39:876-889.
48. Duarte A.I., Proenca T., Oliveira C.R., Santos M.S., Rego A.C. Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress. Diabetes 2006, 55:2863-2870.
49. Duarte A.I., Santos P., Oliveira C.R., Santos M.S., Rego A.C. Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3beta signaling pathways and changes in protein expression. Biochim. Biophys. Acta 2008, 1783:994-1002.
50. Eggler A.L., Liu G., Pezzuto J.M., van Breemen R.B., Mesecar A.D. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc. Natl. Acad. Sci. USA 2005, 102:10070-10075.
51. Eizirik D.L., Flodstrom M., Karlsen A.E., Welsh N. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 1996, 39:875-890.
52. Ekshyyan O., Aw T.Y. Decreased susceptibility of differentiated PC12 cells to oxidative challenge: relationship to cellular redox and expression of apoptotic protease activator factor-1. Cell Death Differ. 2005, 12:1066-1077.
53. El Midaoui A., De Champlain J. Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes. J. Hypertens. 2005, 23:581-588.
54. Elrod J.W., Duranski M.R., Langston W., Greer J.J., Tao L., Dugas T.R., Kevil C.G., Champion H.C., Lefer D.J. ENOS gene therapy exacerbates hepatic ischemia-reperfusion injury in diabetes: a role for eNOS uncoupling. Circ. Res. 2006, 99:78-85.
55. Evans M., Anderson R.A., Smith J.C., Khan N., Graham J.M., Thomas A.W., Morris K., Deely D., Frenneaux M.P., Davies J.S., Rees A. Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus. Eur. J. Clin. Invest. 2003, 33:231-238.
56. Favreau L.V., Pickett C.B. The rat quinone reductase antioxidant response element. Identification of the nucleotide sequence required for basal and inducible activity and detection of antioxidant response element-binding proteins in hepatoma and non-hepatoma cell lines. J. Biol. Chem. 1995, 270:24468-24474.
57. Fenton H.J.H. Oxidation of tartaric acid in presence of iron. J. Chem. Soc. 1894, 65:889-910.
58. Fierro-Gonzalez J.C., Cornils A., Alcedo J., Miranda-Vizuete A., Swoboda P. The thioredoxin TRX-1 modulates the function of the insulin-like neuropeptide DAF-28 during dauer formation in Caenorhabditis elegans. PLoS ONE 2011, 6:16561.
59. Fleming I., Busse R. Signal transduction of eNOS activation. Cardiovasc. Res. 1999, 43:532-541.
60. Flores S.C., Marecki J.C., Harper K.P., Bose S.K., Nelson S.K., McCord J.M. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc. Natl. Acad. Sci. USA 1993, 90:7632-7636.
61. Fraga C.G., Shigenaga M.K., Park J.W., Degan P., Ames B.N. Oxidative damage to DNA during aging: 8-hydroxy-2-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. USA 1990, 87:4533-4537.
62. Frances D.E., Ronco M.T., Monti J.A., Ingaramo P.I., Pisani G.B., Parody J.P., Pellegrino J.M., Sanz P.M., Carrillo M.C., Carnovale C.E. Hyperglycemia induces apoptosis in rat liver through the increase of hydroxyl radical: new insights into the insulin effect. J. Endocrinol. 2010, 205:187-200.
63. Galloway D.C., Blake D.G., McLellan L.I. Regulation of gamma-glutamylcysteine synthetase regulatory subunit (GLCLR) gene expression: identification of the major transcriptional start site in HT29 cells. Biochim. Biophys. Acta 1999, 1446:47-56.
64. Gao F., Gao E., Yue T.L., Ohlstein E.H., Lopez B.L., Christopher T.A., Ma X.L. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002, 105:1497-1502.
65. Garcia-Fernandez M., Castilla-Cortazar I., Diaz-Sanchez M., Navarro I., Puche J.E., Castilla A., Casares A.D., Clavijo E., Gonzalez-Baron S. Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis. BMC Gastroenterol. 2005, 5:7-14.
66. García-Fernández M., Delgado G., Puche J.E., González-Barón S., Cortázar I.C. Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats. Endocrinology 2008, 149:2433-2442.
67. Gatsko G.G., Zhukova A.S., Pozdniakova E.A. Age-related characteristics of the effect of insulin on lipolysis and lipid peroxidation in the adipose tissue of rats. Probl. Endokrinol. (Mosk) 1983, 29:86-89.
68. Geraldes P., Yagi K., Ohshiro Y., He Z., Maeno Y., Yamamoto-Hiraoka J., Rask-Madsen C., Chung S.W., Perrella M.A., King G.L. Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/phosphoinositide 3-kinase/Akt-2 pathway. J. Biol. Chem. 2008, 283:34327-34336.
69. Ghanim H., Sia C.L., Korzeniewski K., Lohano T., Abuaysheh S., Marumganti A., Chaudhuri A., Dandona P. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J. Clin. Endocrinol. Metab. 2011, 96:1409-1414.
70. Gustafsson H., Soderdahl T., Jonsson G., Bratteng J.O., Forsby A. Insulin-like growth factor type 1 prevents hyperglycemia-induced uncoupling protein 3 down-regulation and oxidative stress. J. Neurosci. Res. 2004, 77:285-291.
71. Ha H., Kim C., Son Y.S., Chung M.H., Kim K.H. DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic. Biol. Med. 1994, 16:271-274.
72. Halliwell B., Gutteridge J.M.C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 1984, 219:1-14.
73. Hamden K., Boujbiha M.A., Masmoudi H., Ayadi F.M., Jamoussi K., Elfeki A. Combined vitamins (C and E) and insulin improve oxidative stress and pancreatic and hepatic injury in alloxan diabetic rats. Biomed. Pharmacother. 2009, 63:95-99.
74. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 2005, 45:51-88.
75. Heck S., Lezoualc'h F., Engert S., Behl C. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB. J. Biol. Chem. 1999, 274:9828-9835.
76. Henningsson R., Alm P., Ekström P., Lundquist I. Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study. Diabetes 1999, 48:66-76.
77. Hermann C., Assmus B., Urbich C., Zeiher A.M., Dimmeler S. Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2000, 20:402-409.
78. Hintze K.J., Keck A.S., Finley J.W., Jeffery E.H. Induction of hepatic thioredoxin reductase activity by sulforaphane, both in Hepa1c1c7 cells and in male Fisher 344 rats. J. Nutr. Biochem. 2003, 14:173-179.
79. Hoehn K.L., Salmon A.B., Hohnen-Behrens C., Turner N., Hoy A.J., Maghzal G.J., Stocker R., Van Remmen H., Kraegen E.W., Cooney G.J., Richardson A.R., James D.E. Insulin resistance is a cellular antioxidant defense mechanism. Proc. Natl. Acad. Sci. USA 2009, 106:17787-17792.
80. Hoeldtke R.D., Bryner K.D., McNeill D.R., Warehime S.S., Van Dyke K., Hobbs G. Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes. J. Clin. Endocrinol. Metab. 2003, 88:1624-1628.
81. Holmgren A. Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J. Biol. Chem. 1979, 254:9627-9632.
82. Hong F., Kwon S.J., Jhun B.S., Kim S.S., Ha J., Kim S.J., Sohn N.W., Kang C., Kang I. Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Life Sci. 2001, 68:1095-1105.
83. Howell N.J., Ashrafian H., Drury N.E., Ranasinghe A.M., Contractor H., Isackson H., Calvert M., Williams L.K., Freemantle N., Quinn D.W., Green D., Frenneaux M., Bonser R.S., Mascaro J.G., Graham T.R., Rooney S.J., Wilson I.C., Pagano D. Glucose-insulin-potassium reduces the incidence of low cardiac output episodes after aortic valve replacement for aortic stenosis in patients with left ventricular hypertrophy. Circulation 2011, 123:170-177.
84. Hussain M.A., Schmitz O., Mengel A., Keller A., Christiansen J.S., Zapf J., Froesch E.R. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J. Clin. Invest. 1993, 92:2249-2256.
85. Ishii T., Itoh K., Sato H., Bannai S. Oxidative stress-inducible proteins in macrophages. Free Radic. Res. 1999, 31:351-355.
86. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
87. Itoh K., Wakabayashi N., Katoh Y., Ishii T., O'Connor T., Yamamoto M. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 2003, 8:379-391.
88. Jain M., Brenner D.A., Cui L., Lim C.C., Wang B., Pimentel Dr., Koh S., Sawyer D.B., Leopold J.A., Handy De., Loscalzo J., Apstein C.S., Liao R. Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes. Circ. Res. 2003, 93:9-16.
89. Ji L., Fu F., Zhang L., Liu W., Cai X., Zhang L., Zheng Q., Zhang H., Gao F. Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am. J. Physiol. Endocrinol. Metab. 2010, 298:871-880.
90. Kaneki M., Shimizu N., Yamada D., Chang K. Nitrosative stress and pathogenesis of insulin resistance. Antioxid. Redox Signal. 2007, 9:319-329.
91. Kang K.W., Cho M.K., Lee C.H., Kim S.G. Activation of phosphatidylinositol 3-kinase and Akt by tert-butylhydroquinone is responsible for antioxidant response element-mediated rGSTA2 induction in H4IIE cells. Mol. Pharmacol. 2001, 59:1147-1156.
92. Kang K.W., Lee S.J., Park J.W., Kim S.G. Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. Mol. Pharmacol. 2002, 62:1001-1010.
93. Kang S., Song J., Kang H., Kim S., Lee Y., Park D. Insulin can block apoptosis by decreasing oxidative stress via phosphatidylinositol 3-kinase- and extracellular signal-regulated protein kinase-dependent signaling pathways in HepG2 cells. Eur. J. Endocrinol. 2003, 148:147-155.
94. Katyare S.S., Satav J.G. Effect of streptozotocin-induced diabetes on oxidative energy metabolism in rat kidney mitochondria. A comparative study of early and late effects. Diabetes Obes. Metab. 2005, 7:555-562.
95. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Ann. Rev. Pharmacol. Toxicol. 2007, 47:89-116.
96. Kerr S., Brosnan M.J., Mcintyre M., Reid J.L., Dominiczak A.F., Hamilton C.A. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 1999, 33:1353-1358.
97. Kim S.K., Woodcroft K.J., Novak R.F. Insulin and glucagon regulation of glutathione S-transferase expression in primary cultured rat hepatocytes. J. Pharmacol. Exp. Ther. 2003, 305:353-361.
98. Kim S.K., Woodcroft K.J., Khodadadeh S.S., Novak R.F. Insulin signaling regulates gamma-glutamylcysteine ligase catalytic subunit expression in primary cultured rat hepatocytes. J. Pharmacol. Exp. Ther. 2004, 311:99-108.
99. Kim S.K., Abdelmegeed M.A., Novak R.F. Identification of the insulin signaling cascade in the regulation of alpha-class glutathione S-transferase expression in primary cultured rat hepatocytes. J. Pharmacol. Exp. Ther. 2006, 316:1255-1261.
100. Kimura T., Kawasaki Y., Okumura F., Sone T., Natsuki R., Isobe M. Ethanol-induced expression of glutamate-cysteine ligase catalytic subunit gene is mediated by NF-kappaB. Toxicol. Lett. 2009, 185:110-115.
101. Kobayashi T. Possible involvement of insulin and oxidative stress in vascular dysfunction of diabetic mellitus. Yakugaku Zasshi 2008, 128:1013-1021.
102. Kobayashi T., Kamata K. Relationship among cholesterol, superoxide anion and endothelium-dependent relaxation in diabetic rats. Eur. J. Pharmacol. 1999, 367:213-222.
103. Kocic R., Pavlovic D., Kocic G. Impact of intensive insulin treatment on the development and consequences of oxidative stress in insulin-dependent diabetes mellitus. Vojnosanit. Pregl. 2007, 64:623-628.
104. Kokoszko A., Lewinski A., Karbownik-Lewinska M. The role of growth hormone and insulin-like growth factor I in oxidative processes. Endokrynol. Pol. 2008, 59:496-501.
105. Kondo H., Mori S., Takino H., Kijima H., Yamasaki H., Ozaki M., Tetsuya I., Urata Y., Abe T., Sera Y., Yamakawa K., Kawasaki E., Yamaguchi Y., Kondo T., Eguchi K. Attenuation of expression of gamma-glutamylcysteine synthetase by ribozyme transfection enhance insulin secretion by pancreatic beta cell line, MIN6. Biochem. Biophys. Res. Commun. 2000, 278:236-240.
106. Koo J.R., Vaziri N.D. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney Int. 2003, 63:195-201.
107. Kostyuk E., Svichar N., Shishkin V., Kostyuk P. Role of mitochondrial dysfunction in calcium signalling alterations in dorsal root ganglion neurons of mice with experimentally-induced diabetes. Neuroscience 1999, 90:535-541.
108. Kulenović I., RaŠić S., Grujić M. Metabolic control and body mass index in patients with type 1 diabetes on different insulin regimens. Bosn. J. Basic Med. Sci. 2004, 4:23-28.
109. Kwak M.K., Wakabayashi N., Itoh K., Motohashi H., Yamamoto M., Kensler T.W. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem. 2003, 278:8135-8145.
110. Langouche L., Vanhorebeek I., Vlasselaers D., Vander P.S., Wouters P.J., Skogstrand K., Hansen T.K., Van den Berghe G. Intensive insulin therapy protects the endothelium of critically ill patients. J. Clin. Invest. 2005, 115:2277-2286.
111. Langston W., Circu M.L., Aw T.Y. Insulin stimulation of gamma-glutamylcysteine ligase catalytic subunit expression increases endothelial GSH during oxidative stress: influence of low glucose. Free Radic. Biol. Med. 2008, 45:1591-1599.
112. Lavrovsky Y., Schwartzman M.L., Levere R.D., Kappas A., Abraham N.G. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc. Natl. Acad. Sci. USA 1994, 91:5987-5991.
113. Lee H.G., Li M., Joung E., Na H., Cha Y., Surh Y. Nrf2-mediated heme oxygenase-1 upregulation as adaptive survival response to glucose deprivation-induced apoptosis in HepG2 cells. Antioxid. Redox Signal. 2010, 13:1639-1648.
114. Leelayuwat N., Tunkumnerdthai O., Donsom M., Punyaek N., Manimanakorn A., Kukongviriyapan U., Kukongviriyapan V. An alternative exercise and its beneficial effects on glycaemic control and oxidative stress in subjects with type 2 diabetes. Diabetes Res. Clin. Pract. 2008, 82:5-8.
115. Li S., Li X., Rozanski G.J. Regulation of glutathione in cardiac myocytes. J. Mol. Cell. Cardiol. 2003, 35:1145-1152.
116. Li S., Li X., Li Y.L., Shao C.H., Bidasee K.R., Rozanski G.J. Insulin regulation of glutathione and contractile phenotype in diabetic rat ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:1619-1629.
117. Li R., Wang W.Q., Zhang H., Yang X., Fan Q., Christopher T.A., Lopez B.L., Tao L., Goldstein B.J., Gao F., Ma X.L. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. Am. J. Physiol. Endocrinol. Metab. 2007, 293:1703-1708.
118. Liu, Y., Ma, Y., Wang, R., Xia, C., Zhang, R., Lian, K., Luan, R., Sun, L., Yang, L., Lau, W.B., Wang, H., Tao, L., 2010. Advanced glycation end products accelerate ischemia/reperfusion injury through RAGE/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells. Antioxid. Redox Signal.
119. Liu S., Okada T., Assmann A., Soto J., Liew C.W., Bugger H., Shirihai O.S., Abel E.D., Kulkarni R.N. Insulin signaling regulates mitochondrial function in pancreatic beta-cells. PLoS ONE 2009, 4:7983.
120. Loven D., Schedl H., Wilson H., Daabees T.T., Stegink L.D., Diekus M., Oberley L. Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozocin-induced diabetes. Diabetes 1986, 35:503-507.
121. Lu S.C., Ge J.L., Kuhlenkamp J., Kaplowitz N. Insulin and glucocorticoid dependence of hepatic gamma-glutamylcysteine synthetase and glutathione synthesis in the rat. Studies in cultured hepatocytes and in vivo. J. Clin. Invest. 1992, 90:524-532.
122. Luan R., Liu S., Yin T., Lau W.B., Wang Q., Guo W., Wang H., Tao L. High glucose sensitizes adult cardiomyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation. Cardiovasc. Res. 2009, 83:294-302.
123. Lyras L., Cairns N.J., Jenner A., Jenner P., Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 1997, 68:2061-2069.
124. Ma Q. Xenobiotic-activated receptors: from transcription to drug metabolism to disease. Chem. Res. Toxicol. 2008, 21:1651-1671.
125. MacLeod A.K., McMahon M., Plummer S.M., Higgins L.G., Penning T.M., Igarashi K., Hayes J.D. Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 2009, 30:1571-1580.
126. Maeda H., Rajesh K.G., Maeda H., Suzuki R., Sasaguri S. Epidermal growth factor and insulin inhibit cell death in pancreatic beta cells by activation of PI3-kinase/AKT signaling pathway under oxidative stress. Transplant. Proc. 2004, 36:1163-1165.
127. Matsumoto T., Yoshiyama S., Wakabayashi K., Kobayashi T., Kamata K. Effects of chronic insulin on endothelial dysfunction of basilar arteries from established streptozotocin-diabetic rats. Eur. J. Pharmacol. 2004, 504:119-127.
128. Mayhan W.G. Superoxide dismutase partially restores impaired dilatation of the basilar artery during diabetes mellitus. Brain Res. 1997, 760:109-204.
129. McGowan J.E., Chen L., Gao D., Trush M., Wei C. Increased mitochondrial reactive oxygen species production in newborn brain during hypoglycemia. Neurosci. Lett. 2006, 399:111-114.
130. McMahon M., Thomas N., Itoh K., Yamamoto M., Hayes J.D. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a " tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J. Biol. Chem. 2006, 281:24756-24768.
131. Medina-Navarro R., Guzman-Grenfell A.M., Olivares-Corichi I., Hicks J.J. Structural and functional changes in the insulin molecule produced by oxidative stress. Methods Mol. Biol. 2010, 594:141-153.
132. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 1983, 52:711-760.
133. Miele M., Esposito G., Migheli R., Sircana S., Zangani D., Fresu G.L., Desole M.S. Effects of allopurinol on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurochemical changes in the striatum and in the brainstem of the rat. Neurosci. Lett. 1995, 183:155-159.
134. Monge M., Ledeme N., Mazouz H., Lalau J.D., Moubarak M., Presne C., Fournier A., Maziere J.C., Choukroun G., Westeel P.F. Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantation. Nephrol. Dial. Transplant. 2007, 22:1979-1985.
135. Monnier, L., Colette, C., Michel, F., Cristol, J.P., Owens, D.R., 2011. Insulin exerts a hormetic effect on oxidative stress in type 2 diabetes: a cause for concern? Diabetes Metab. Res. Rev.
136. Monnier L., Colette C., Mas E., Michel F., Cristol J.P., Boegner C., Owens D.R. Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy. Diabetologia 2010, 53:562-571.
137. Montes-Cortes D.H., Hicks J.J., Ceballos-Reyes G.M., Garcia-Sanchez J.R., Medina-Navarro R., Olivares-Corichi I.M. Chemical and functional changes of human insulin by in vitro incubation with blood from diabetic patients in oxidative stress. Metabolism 2010, 59:935-942.
138. Moreira P.I., Santos M.S., Sena C., Seica R., Oliveira C.R. Insulin protects against amyloid beta-peptide toxicity in brain mitochondria of diabetic rats. Neurobiol. Dis. 2005, 18:628-637.
139. Moreira P.I., Rolo A.P., Sena C., Seica R., Oliveira C.R., Santos M.S. Insulin attenuates diabetes-related mitochondrial alterations: a comparative study. Med. Chem. 2006, 2:299-308.
140. Mosén H., Salehi A., Alm P., Henningsson R., Jimenez-Feltström J., Ostenson C., Efendic S., Lundquist I. Defective glucose-stimulated insulin release in the diabetic Goto-Kakizaki (GK) rat coincides with reduced activity of the islet carbon monoxide signaling pathway. Endocrinology 2005, 146:1553.
141. Mosén H., Salehi A., Henningsson R., Lundquist I. Nitric oxide inhibits and carbon monoxide activates, islet acid α-glucoside hydrolase activities in parallel with glucose-stimulated insulin secretion. J. Endocrinol. 2006, 190:681.
142. Muin J.K., Rodolfo V., Ann A. Public health genomics approach to type 2 diabetes. Diabetes 2008, 57:2911-2914.
143. Mulcahy R.T., Wartman M.A., Bailey H.H., Gipp J.J. Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J. Biol. Chem. 1997, 272:7445-7454.
144. Nakaso K., Yano H., Fukuhara Y., Takeshima T., Wada-Isoe K., Nakashima K. PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett. 2003, 546:181-184.
145. Ndisang J.F., Jadhav A. Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats. Endocrinology 2009, 150:2627-2636.
146. Ndisang J.F., Jadhav A. Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. Am. J. Physiol. Endocrinol. Metab. 2009, 296:829-841.
147. Ndisang J.F., Lane N., Jadhav A. Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2009, 296:1029-1041.
148. Ndisang J.F., Lane N., Syed N., Jadhav A. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology 2010, 151:549-560.
149. Nguyen T., Sherratt P.J., Pickett C.B. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 2003, 43:233-260.
150. Noh K.M., Lee J.C., Ahn Y.H., Hong S.H., Koh J.Y. Insulin-induced oxidative neuronal injury in cortical culture: mediation by induced N-methyl-d-aspartate receptors. IUBMB Life 1999, 48:263-269.
151. Nordberg J., Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 2001, 31:1287-1312.
152. Offen D., Shtaif B., Hadad D., Weizman A., Melamed E., Gil-Ad I. Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson's disease. Neurosci. Lett. 2001, 316:129-132.
153. Okouchi M., Okayama N., Alexander J.S., Aw T.Y. NRF2-dependent glutamate-l-cysteine ligase catalytic subunit expression mediates insulin protection against hyperglycemia-induced brain endothelial cell apoptosis. Curr. Neurovasc. Res. 2006, 3:249-261.
154. Omar B.A., McCord J.M. Interstitial equilibration of superoxide dismutase correlates with its protective effect in the isolated rabbit heart. J. Mol. Cell. Cardiol. 1991, 23:149-159.
155. Otsyula M., King M.S., Ketcham T.G., Sanders R.A., Watkins J.B. Oxidative stress in rats after 60 days of hypergalactosemia or hyperglycemia. Int. J. Toxicol. 2003, 22:423-427.
156. Ozaki M., Yamasaki H., Kondo H., Yamasaki S., Fujita N., Yamauchi M.D., Abe T., Yamakawa K., Sera Y., Uotani S., Kawasaki E., Takino H., Kijima H., Kondo T., Yamaguchi Y., Eguchi K. Enhanced insulin gene expression by reduced intracellular glutathione level in insulin secreting cells MIN6. Diabetes Nutr. Metab. 2003, 16:81-87.
157. Paolisso G., Giugliano D., Pizza G., Gambardella A., Tesauro P., Varricchio M., D'Onofrio F. Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care 1992, 15:1-7.
158. Park K.S., Kim J.H., Kim M.S., Kim J.M., Kim S.K., Choi J.Y., Chung M.H., Han B., Kim S.Y., Lee H.K. Effects of insulin and antioxidant on plasma 8-hydroxyguanine and tissue 8-hydroxydeoxyguanosine in streptozotocin-induced diabetic rats. Diabetes 2001, 50:2837-2841.
159. Park H.S., Kim M.S., Huh S.H., Park J., Chung J., Kang S.S., Choi E.J. Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J. Biol. Chem. 2002, 277:2573-2578.
160. Poduslo J.F., Curran G.L., Berg C.T. Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc. Natl. Acad. Sci. USA 1994, 91:5705-5709.
161. Rada P., Rojo A.I., Chowdhry S., McMahon M., Hayes J.D., Cuadrado A. SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol. Cell. Biol. 2011, 31:1121-1133.
162. Ricci C., Pastukh V., Mozaffari M., Schaffer S.W. Insulin withdrawal induces apoptosis via a free radical-mediated mechanism. Can. J. Physiol. Pharmacol. 2007, 85:455-464.
163. Rizvi S.I., Zaid M.A. Intracellular reduced glutathione content in normal and type 2 diabetic erythrocytes: effect of insulin and (-)epicatechin. J. Physiol. Pharmacol. 2001, 52:483-488.
164. Rojo A.I., Sagarra M.R., Cuadrado A. GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J. Neurochem. 2008, 105:192-202.
165. Rushmore T.H., Pickett C.B. Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J. Biol. Chem. 1990, 265:14648-14653.
166. Ryu B.R., Ko H.W., Jou I., Noh J.S., Gwag B.J. Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I. J. Neurobiol. 1999, 39:536-546.
167. Sal'nikova L.A., Musatova N.V. The action of insulin on the antioxidative enzymes and lipid peroxidation in the erythrocytes. Probl. Endokrinol. (Mosk) 1990, 36:32-34.
168. Sano T., Umeda F., Hashimoto T., Nawata H., Utsumi H. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. Diabetologia 1998, 41:1355-1360.
169. Sanz A., Gredilla R., Pamplona R., Portero-Otin M., Vara E., Tresguerres J.A., Barja G. Effect of insulin and growth hormone on rat heart and liver oxidative stress in control and caloric restricted animals. Biogerontology 2005, 6:15-26.
170. Sara V.R., Hall K. Insulin-like growth factor-I and their binding proteins. Physiol. Rew. 1990, 70:591-613.
171. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 2001, 30:1191-1212.
172. Schiel R., Franke S., Appel T., Voigt U., Ross I.S., Kientsch-Engel R., Muller U.A., Stein G. Improvement of the quality of diabetes control and decrease in the concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus: results from a 10 year-prospective, population-based survey on the quality of diabetes care in Germany (JEVIN). Eur. J. Med. Res. 2004, 9:391-399.
173. Schubert M., Gautam D., Surjo D., Ueki K., Baudler S., Schubert D., Kondo T., Alber J., Galldiks N., Kustermann E., Arndt S., Jacobs A.H., Krone W., Kahn C.R., Bruning J.C. Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 2004, 101:3100-3105.
174. Seghrouchni I., Drai J., Bannier E., Rivière J., Calmard P., Garcia I., Orgiazzi J., Revol A. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin. Chim. Acta 2002, 321:89-96.
175. Seghrouchni I., Drai J., Bannier E., Riviere J., Calmard P., Garcia I., Orgiazzi J., Revol A. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin. Chim. Acta 2002, 321:89-96.
176. Selemidis S., Sobey C.G., Schmidt H.H.H.W., Wingler K., Drummond G.R. NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol. Ther. 2008, 120:254-291.
177. Sevanian A., Davies K.J.A., Hochstein P. Serum urate as an antioxidant for ascorbic acid. Am. J. Clin. Nutr. 1991, 54:129-134.
178. Shaked M., Ketzinel-Gilad M., Ariav Y., Cerasi E., Kaiser N., Leibowitz G. Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus ancreatic islets. Diabetologia 2009, 52:636-644.
179. Shamir R., Shehadeh N., Rosenblat M., Eshach-Adiv O., Coleman R., Kaplan M., Hamoud S., Lischinsky S., Hayek T. Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23:104-110.
180. Si R., Tao L., Zhang H.F., Yu Q.J., Zhang R., Lv A.L., Zhou N., Cao F., Guo W.Y., Ren J., Wang H.C., Gao F. Survivin: a novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 2011, 50:16-24.
181. Sindhu R.K., Koo J.R., Roberts C.K., Vaziri N.D. Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies. Clin. Exp. Hypertens. 2004, 26:43-53.
182. Sodi-Pallares D., Testelli M.R., Fishleder B.L., Bisteni A., Medrano G.A., Friedland C., De Micheli A. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am. J. Cardiol. 1962, 9:166-181.
183. Somogyi A., Ruzicska E., Blazovics A., Ver A., Rosta K., Toth M. Insulin treatment decreases the antioxidant defense mechanism in experimental diabetes. Med. Sci. Monit. 2005, 11:206-211.
184. Sortino M.A., Canonico P.L. Neuroprotective effect of insulin-like growth factor I in immortalized hypothalamic cells. Endocrinology 1996, 137:1418-1422.
185. Storgaard H., Song X.M., Jensen C.B., Madsbad S., Bjornholm M., Vaag A., Zierath J.R. Insulin signal transduction in skeletal muscle from glucoseintolerant relatives with type 2 diabetes. Diabetes 2001, 50:2770-2778.
186. Stump C.S., Short K.R., Bigelow M.L., Schimke J.M., Nair K.S. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc. Natl. Acad. Sci. USA 2003, 100:7996-8001.
187. Stupka, N., Martin, S.D., McKenzie, J.M., Collier, F.M., Konstantopoulos, N., 2008. Glucose and insulin modulate the expression and activity of the thioredoxin antioxidant system in cultured human skeletal muscle fibres. AUPS 2008: Proceedings of the Australian Physiological Society 2008, 1.
188. Tagami S., Kondo T., Yoshida K., Hirokawa J., Ohtsuka Y., Kawakami Y. Effect of insulin on impaired antioxidant activities in aortic endothelial cells from diabetic rabbits. Metabolism 1992, 41:1053-1058.
189. Tao L., Liu H.R., Gao E., Teng Z.P., Lopez B.L., Christopher T.A., Ma X.L., Batinic-Haberle I., Willette R.N., Ohlstein E.H., Yue T.L. Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia. Circulation 2003, 108:2805-2811.
190. Tao L., Gao E., Bryan N.S., Qu Y., Liu H.R., Hu A., Christopher T.A., Lopez B.L., Yodoi J., Koch W.J., Feelisch M., Ma X.L. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected]. Proc. Natl. Acad. Sci. USA 2004, 101:11471-11476.
191. Tao L., Jiao X., Gao E., Lau W.B., Yuan Y., Lopez B., Christopher T., RamachandraRao S.P., Williams W., Southan G., Sharma K., Koch W., Ma X.L. Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation 2006, 114:1395-1402.
192. Tao L., Gao E., Jiao X., Yuan Y., Li S., Christopher T.A., Lopez B.L., Koch W., Chan L., Goldstein B.J., Ma X.L. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 2007, 115:1408-1416.
193. Tchou J., Kasai H., Shibutani S., Chung M.H., Laval J., Grollman A.P., Nishimura S. 8-Oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc. Natl. Acad. Sci. USA 1991, 88:4690-4694.
194. Thomas H., Schladt L., Knehr M., Oesch F. Effect of diabetes and starvation on the activity of rat liver epoxide hydrolases, glutathione S-transferases and peroxisomal beta-oxidation. Biochem. Pharmacol. 1989, 38:4291-4297.
195. Tong K.I., Katoh Y., Kusunoki H., Itoh K., Tanaka T., Yamamoto M. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol. Cell. Biol. 2006, 26:2887-2900.
196. Townsend D.M., Tew K.D. The role of glutathione-S-transferase in anticancer drug resistance. Oncogene 2003, 22:7369-7375.
197. Vaille A., Jadot G., Elizagaray A. Anti-inflammatory activity of various superoxide dismutases on polyarthritis in the Lewis rat. Biochem. Pharmacol. 1990, 39:247-255.
198. Wakabayashi N., Slocum S.L., Skoko J.J., Shin S., Kensler T.W. When NRF2 talks, who's listening?. Antioxid. Redox Signal. 2010, 13:1649-1663.
199. Wang B., Williamson G. Detection of a nuclear protein which binds specifically to the antioxidant responsive element (ARE) of the human NAD(P) H:quinone oxidoreductase gene. Biochim. Biophys. Acta 1994, 1219:645-652.
200. Wang X., Ye X.L., Liu R., Chen H.L., Bai H., Liang X., Zhang X.D., Wang Z., Li W.L., Hai C.X. Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases. Chem. Biol. Interact. 2010, 184:328-337.
201. Wang X., Liu J.Z., Hu J.X., Wu H., Li Y.L., Chen H.L., Bai H., Hai C.X. ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation. Free Radic. Biol. Med. 2011, 51:539-551.
202. Wang X., Li Y.L., Wu H., Liu J.Z., Hu J.X., Liao N., Peng J., Cao P.P., Liang X., Hai C.X. Antidiabetic effect of oleanolic acid: a promising use of a traditional pharmacological agent. Phytother. Res. 2011, 25:1031-1040.
203. 2 in neutrophil recruitment into sites of dermal and pulmonary vasculitis. Free Radic. Biol. Med. 1990, 8:163-172.
204. Wiryana M. The role of intensive insulin therapy in increasing superoxide dismutase (SOD) and normalizing hyperglycemia in critically ill patients. Acta Med. Indones 2009, 41:59-65.
205. Wold L.E., Muralikrishnan D., Albano C.B., Norby F.L., Ebadi M., Ren J. Insulin-like growth factor I (IGF-1) supplementation prevents diabetes-induced alterations in coenzymes Q9 and Q10. Acta Diabetol. 2003, 40:85-90.
206. Wu X., Zhu L., Zilbering A., Mahadev K., Motoshima H., Yao J., Goldstein B.J. Hyperglycemia potentiates H(2)O(2) production in adipocytes and enhances insulin signal transduction: potential role for oxidative inhibition of thiol-sensitive protein-tyrosine phosphatases. Antioxid. Redox Signal. 2005, 7:526-537.
207. Yang W.Y., Lu J.M., Weng J.P., Jia W.P., Ji L.N., Xiao J.Z., Shan Z.Y., Liu J., Tian H.M., Ji Q.H., Zhu D.L., Ge J.P., Lin L.X., Chen L., Guo X.H., Zhao Z.G., Li Q., Zhou Z.G., Shan G.L., He J. Prevalence of diabetes among men and women in China. N. Engl. J. Med. 2010, 362:1090-1101.
208. Yin T., Hou R., Liu S., Lau W.B., Wang H., Tao L. Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 2010, 49:354-361.
209. Yoshida M., Kimura H., Kyuki K., Ito M. Combined effect of vitamin E and insulin on cataracts of diabetic rats fed a high cholesterol diet. Biol. Pharm. Bull. 2004, 27:338-344.
210. Yu X.R., Jia G.R., Gao G.D., Wang S.H., Han Y., Cao W. Neuroprotection of insulin against oxidative stress-induced apoptosis in cultured retinal neurons: involvement of phosphoinositide 3-kinase/Akt signal pathway. Acta Biochim. Biophys. Sin. (Shanghai) 2006, 38:241-248.
211. Yuan Y., Jiao X., Lau W.B., Wang Y., Christopher T.A., Lopez B.L., Ramachandrarao S.P., Tao L., Ma X.L. Thioredoxin glycation: a novel posttranslational modification that inhibits its antioxidant and organ protective actions. Free Radic. Biol. Med. 2010, 49:332-338.
212. Zhang H.S., Wang S.Q. Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells. Biochem. Pharmacol. 2007, 73:1358-1366.
213. Zhang H.F., Fan Q., Qian X.X., Lopez B.L., Christopher T.A., Ma X.L., Gao F. Role of insulin in the anti-apoptotic effect of glucose-insulin-potassium in rabbits with acute myocardial ischemia and reperfusion. Apoptosis 2004, 9:777-783.
214. Zhang H., Tao L., Jiao X., Gao E., Lopez B.L., Christopher T.A., Koch W., Ma X.L. Nitrative thioredoxin inactivation as a cause of enhanced myocardial ischemia/reperfusion injury in the aging heart. Free Radic. Biol. Med. 2007, 43:39-47.
215. Zhao W., Chen H., Xu H., Moore E., Meiri N., Quon M.J., Alkon D. Brain insulin receptors and spatial memory. J. Biol. Chem. 1999, 274:34893-34902.
216. Zhu H., Itoh K., Yamamoto M., Zweier J.L., Li Y. Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury. FEBS Lett. 2005, 579:3029-3036.
217. 2 levels: essential role of cGMP. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:2103-2112.
218. Zipper L.M., Mulcahy R.T. Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes. Biochem. Biophys. Res. Commun. 2000, 278:484-492.
219. Zipper L.M., Mulcahy R.T. Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells. Toxicol. Sci. 2003, 73:124-134.
220. Zobali F., Avci A., Canbolat O., Karasu C. Effects of vitamin A and insulin on the antioxidative state of diabetic rat heart: a comparison study with combination treatment. Cell Biochem. Funct. 2002, 20:75-80.
221. Zobali F., Besler T., Ari N., Karasu C. Hydrogen peroxide-induced inhibition of vasomotor activity: evaluation of single and combined treatments with vitamin A and insulin in streptozotocin-diabetic rats. Int. J. Exp. Diabetes Res. 2002, 3:119-130.
222. Zourek M., Kyselova P., Mudra J., Krcma M., Jankovec Z., Lacigova S., Visek J., Rusavy Z. The relationship between glycemia, insulin and oxidative stress in hereditary hypertriglyceridemic rat. Physiol. Res. 2008, 57:531-538.